151751-Najiba-Chargi

42 CHAPTER 2 REFERENCES 1. Prado CM, Cushen SJ, Orsso CE, Ryan AM. Sarcopenia and cachexia in the era of obe- sity: clinical and nutritional impact. Proc Nutr Soc . 2016;75(2):188-198. doi:10.1017/ S0029665115004279 2. Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: Skel- etal muscle depletion is a powerful prog- nostic factor, independent of body mass index. J Clin Oncol . 2013;31(12):1539-1547. doi:10.1200/JCO.2012.45.2722 3. Levolger S, van Vugt JLA, de Bruin RWF, IJzermans JNM. Systematic review of sarco - penia in patients operated on for gastroin- testinal and hepatopancreatobiliary malig- nancies. Br J Surg . 2015;102(12):1448-1458. doi:10.1002/bjs.9893 4. Rier HN, Jager A, Sleijfer S, Maier AB, Levin M. The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. Oncologist . 2016;21(11):1396-1409. doi:10.1634/theon - cologist.2016-0066 5. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sar- copenic obesity in patients with solid tu- mours of the respiratory and gastrointesti- nal tracts: a population-based study. Lancet Oncol . 2008;9(7):629-635. doi:10.1016/ S1470-2045(08)70153-0 6. Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdom- inal cross-sectional image. J Appl Physiol . 2004;97(6):2333-2338. doi:10.1152/jap - plphysiol.00744.2004 7. Swartz JE, Pothen AJ, Wegner I, et al. Feasibility of using head and neck CT im - aging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol . 2016;62:28-33. doi:10.1016/j.oraloncolo - gy.2016.09.006 8. Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. 2017. doi:10.1016/j.oraloncol - ogy.2017.05.012 9. Bril SI, Pezier TF, Tijink BM, Janssen LM, Braunius WW, Bree R. Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy. Head Neck . 2019;41(6):1745- 1755. doi:10.1002/hed.25638 10. Chargi N, Bril SI, Swartz JE, Wegner I, Wil - lems SW, de Bree R. Skeletal muscle mass is an imaging biomarker for decreased sur- vival in patients with oropharyngeal squa- mous cell carcinoma. Oral Oncol . 2020;101. doi:10.1016/j.oraloncology.2019.104519 11. AchimV, Bash J, Mowery A, et al. Prognostic Indication of Sarcopenia for Wound Com - plication After Total Laryngectomy. JAMA Otolaryngol Neck Surg . 2017;143(12):1159. doi:10.1001/jamaoto.2017.0547 12. Ansari E, Chargi N, van Gemert JTM, et al. Low skeletal muscle mass is a strong pre- dictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular reconstruction with a free fibula flap. Oral Oncol . 2020;101. doi:10.1016/j.oraloncology.2019.104530 13. van Rijn-Dekker MI, van den Bosch L, van den Hoek JGM, et al. Impact of sarcope - nia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol . 2020. doi:10.1016/j.radonc.2020.03.014 14. Ufuk F, Herek D, Yüksel D. Diagnosis of sarcopenia in head and neck computed tomography: Cervical muscle mass as a strong indicator of Sarcopenia. Clin Exp Otorhinolaryngol . 2019. doi:10.21053/ ceo.2018.01613